Syndicated Research Studies

The global international express delivery market was valued at USD 30.96 billion in 2024 and is projected to reach USD 56.00 billion by 2030, expanding at a CAGR of 10.5% from 2025 to 2030. Market expansion is driven by a combination of macroeconomic and sector-specific forces, including the rapid rise of cross-border e-commerce, increasing global trade activity, and the growing consumer expectation for faster delivery services. Enhanced import–export operations and continued supply chain optimization across developed and emerging economies have further strengthened demand for international express logistics. Businesses across retail, pharmaceuticals, and electronics are increasingly relying on express delivery providers to meet advanced B2C fulfillment standards. In response, the industry is rapidly adopting cutting-edge technologies. Automated sorting systems, AI-enabled route optimization, and real-time parcel tracking are now integral to modern express delivery networks. Mea...

The global insect repellent market was valued at USD 5.57 billion in 2024 and is projected to reach USD 8.28 billion by 2030, registering a CAGR of 6.7% from 2025 to 2030. The rising incidence of vector-borne diseases-including malaria, dengue fever, Zika virus, and Lyme disease-continues to drive the demand for insect repellents. These diseases, transmitted by mosquitoes, ticks, and other insects, pose growing health risks across regions. As awareness increases, particularly in areas where disease outbreaks are expanding due to climate shifts, consumers and communities are prioritizing preventive measures such as insect repellent products. The rising adoption of landscaping elements-including plants, water features, and gazebos-is also contributing to demand for home and garden pesticides. Additionally, the growing trend of transforming outdoor residential and commercial spaces into aesthetically appealing areas such as lawns, outdoor kitchens, and entertainment zones is supporting ...

The global injectable drug delivery devices market is anticipated to reach USD 823.29 billion by 2030, expanding at a CAGR of 8.4% from 2024 to 2030. The market is being propelled by the rising prevalence of chronic diseases and rapid technological advancements in drug delivery systems. Additionally, government initiatives aimed at enhancing access to injectable therapies for chronic conditions are further supporting market expansion. Chronic diseases—including diabetes, cancer, and autoimmune disorders—continue to rise worldwide. According to the World Health Organization (WHO), illnesses such as diabetes, cancer, and cardiovascular diseases account for more than 70% of global deaths. These conditions frequently require long-term injectable treatments, significantly boosting the demand for advanced drug delivery devices. Moreover, the United Nations estimates that the global population aged 65 and above will reach 1.6 billion by 2050. As older adults are more prone to chr...

Pet Food Ingredients Market Summary The global pet food ingredients market is expected to reach USD 83.60 billion by 2030, expanding at a CAGR of 4.9% from 2024 to 2030. Rising global pet adoption and the growing trend of pet humanization—accelerated by the work-from-home culture—have strengthened consumer awareness of pets' nutritional requirements, thereby driving demand in the pet food ingredients sector. The COVID-19 pandemic positively influenced market growth, as increased pet adoption during lockdowns led to a significant rise in the demand for pet food ingredients. Many consumers stocked up on pet food during the initial lockdown phase due to concerns about supply shortages. Moreover, extended time spent at home encouraged stronger emotional bonds between pet owners and their pets, intensifying the trend of treating pets as family members. Greater awareness of pets’ health-specific needs has also boosted demand for premium and specialized nutrition. Work-fr...

Regenerative Medicine Market Summary The global regenerative medicine market was valued at USD 35.47 billion in 2024 and is expected to reach USD 90.01 billion by 2030, expanding at a CAGR of 16.83% from 2025 to 2030. Ongoing advancements in biological therapies have driven a shift toward personalized medical approaches, creating strong growth opportunities for companies developing biologic therapeutics. The rising prevalence of degenerative diseases has heightened the need for research aimed at identifying innovative regenerative treatments. The COVID-19 pandemic also influenced the field significantly, disrupting regenerative medicine and T-cell therapy manufacturing. The widespread impact of SARS-CoV-2 affected not only patient care but also administration, logistics, and clinical research operations. Numerous institutions temporarily slowed clinical trial enrollments and related research. Despite these challenges, the market remains on an upward trajectory as industry players su...

The global quantum computing market was valued at USD 1.42 billion in 2024 and is expected to reach USD 4.24 billion by 2030, expanding at a CAGR of 20.5% from 2025 to 2030. The quantum computing landscape is rapidly evolving, supported by a growing number of startups that are entering the industry and focusing on diverse elements of quantum technology, including hardware, software, and application development. Both government bodies and private organizations are significantly increasing investments in quantum research and development to secure leadership in this pivotal emerging technology. Quantum computing remains at an early yet high-potential stage, distinguished by its use of qubits, which-unlike classical bits-can represent both 0 and 1 simultaneously. This characteristic enables quantum computers to process certain highly complex calculations much more efficiently than traditional systems. The unique computational capabilities of quantum computing position it to transform se...